Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro
| Quartal / Datum | EPS () | Schätzung () | Abweichung |
|---|
| Quartal / Datum | Umsatz (Mio ) | Schätzung (Mio ) | Abweichung |
|---|